483 related articles for article (PubMed ID: 17428293)
1. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
2. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
Wong M; Helston LM; Wells PG
Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute glutathione depletion induced by L-buthionine-(S,R)-sulfoximine on rat liver glucose-6-phosphatase activity.
Santori G; Domenicotti C; Bellocchio A; Pronzato MA; Marinari UM; Poli G; Cottalasso D
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):165-78. PubMed ID: 9467825
[TBL] [Abstract][Full Text] [Related]
6. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1.
Wu D; Cederbaum AI
Alcohol Clin Exp Res; 2001 Apr; 25(4):619-28. PubMed ID: 11329505
[TBL] [Abstract][Full Text] [Related]
7. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
8. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms.
Lüthen RE; Neuschwander-Tetri BA; Niederau C; Ferrell LD; Grendell JH
Int J Pancreatol; 1994 Aug; 16(1):31-6. PubMed ID: 7528760
[TBL] [Abstract][Full Text] [Related]
9. Sex difference in susceptibility to acetaminophen hepatotoxicity is reversed by buthionine sulfoximine.
Masubuchi Y; Nakayama J; Watanabe Y
Toxicology; 2011 Sep; 287(1-3):54-60. PubMed ID: 21672600
[TBL] [Abstract][Full Text] [Related]
10. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature.
Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F
Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
[TBL] [Abstract][Full Text] [Related]
12. Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.
Larosche I; Choumar A; Fromenty B; Lettéron P; Abbey-Toby A; Van Remmen H; Epstein CJ; Richardson A; Feldmann G; Pessayre D; Mansouri A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):326-38. PubMed ID: 19063909
[TBL] [Abstract][Full Text] [Related]
13. Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase.
Kessova IG; Ho YS; Thung S; Cederbaum AI
Hepatology; 2003 Nov; 38(5):1136-45. PubMed ID: 14578852
[TBL] [Abstract][Full Text] [Related]
14. Buthionine sulfoximine embryotoxicity is associated with prolonged AP-1 activation.
Ozolins TR; Harrouk W; Doerksen T; Trasler JM; Hales BF
Teratology; 2002 Oct; 66(4):192-200. PubMed ID: 12353216
[TBL] [Abstract][Full Text] [Related]
15. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
Miller AC; Henderson BW
J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
[TBL] [Abstract][Full Text] [Related]
16. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo.
Gokce G; Ozsarlak-Sozer G; Oktay G; Kirkali G; Jaruga P; Dizdaroglu M; Kerry Z
Biochemistry; 2009 Jun; 48(22):4980-7. PubMed ID: 19374446
[TBL] [Abstract][Full Text] [Related]
18. Buthionine sulfoximine causes endothelium dependent hyper-relaxation and hypoadiponectinemia.
Iwata C; Wang X; Uchida K; Nakanishi N; Hattori Y
Life Sci; 2007 Feb; 80(9):873-8. PubMed ID: 17137603
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion enhances the formation of endogenous cyclic DNA adducts derived from t-4-hydroxy-2-nonenal in rat liver.
Chung FL; Komninou D; Zhang L; Nath R; Pan J; Amin S; Richie J
Chem Res Toxicol; 2005 Jan; 18(1):24-7. PubMed ID: 15651845
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxia and glutathione depletion in the isolated perfused rat liver.
Shattuck KE; Grinnell CD; Keeney SE; Noworyta K; Rassin DK
J Investig Med; 1997 Dec; 45(9):576-83. PubMed ID: 9444885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
